Temozolomide as 2nd-3rd Line Treatment of Patients with Poorly Differentiated Neuroendocrine Carcinomas

Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date2011
Number of pages1
Publication statusPublished - 2011
Event8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease - Lisbon, Portugal
Duration: 9 Mar 201111 Mar 2011

Conference

Conference8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease
CountryPortugal
CityLisbon
Period09/03/201111/03/2011

ID: 257379666